Cilostazol
Product Images NDC 68151-3844

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cilostazol (NDC 68151-3844). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

FDA Label Image

Figure-1.jpg (Image 02)

Figure-1.jpg (Image 02)
This is a graph showing the plasma concentration (in ng/mL) over time (in hours) for three drugs: Gilostazol, 3,4-defydrodlostazal, and 4Htrans-hydroxyailostazol. The concentration of Gilostazol begins at around 1600 ng/mL and steadily decreases over time. The concentration of 3,4-defydrodlostazal begins at around 800 ng/mL and slowly increases over time. The concentration of 4Htrans-hydroxyailostazol hovers around 800 ng/mL throughout the entire timeframe displayed on the graph.*
FDA Label Image

Figure 2 (Image 03)

FDA Label Image

Label Image (Lbl681513844)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.